Search Results

You are looking at 21 - 30 of 50 items for :

  • Hashimoto’s thyroiditis x
Clear All
Open access

R. Mekova and M. Boyanov

. Nuklearmedizin 2004; 43: 124-128. 4. Gilmour J, Brownlee Y, Foster P, et al. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto’s disease, Graves’ disease and a follow-up study on postpartum thyroid disease. Clin Lab 2000; 46: 57-61. 5. McLachlan SM, Rapoport B. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid 2004; 14: 510-520. 6. Ogawa T, Sakata S, Nakamura S, et al. Thyroid hormone autoantibodies in patients with

Open access

Remziye Eren, Hamide Sayar, Harun Çiralik and Fikret Ezberci

extensive squamous metaplasia: A potential diagnostic pitfall on thyroid aspiration. South Med J 2010, 103:268-271 11. Bond JA, Wyllie FS, Ivan M, Dawson T, Wynford-Thomas D: A variant epithelial sub-population in normal thyroid with high proliferative capacity in vitro. Mol Cell Endocrinol 1993, 93: 175-183 12. Musso-Lassalle S, Butori C, Bailleux S, Santini J, Franc B, Hofman P: Diagnostic pitfall: Nodular tumor-like squamous metaplasia with Hashimoto’s thyroiditis mimicking a sclerosing mucoepidermoid carcinoma with eosinophilia

Open access

Zorica Jovanovic, Svetlana Miletic-Drakulic, Gordana Toncev, Olgica Mihaljevic, Svetlana Djukic, Jasna Jevdjic and Snezana Zivancevic-Simonovic

four models predicting fatigue in multiple sclerosis. Arch Clin Neuropsychol 2005; 20: 631-46. 18. Zivancevic-Simonovic S, Djukic A, Arsenijevic N, Dimitrijevic Lj. Autoimunska bolest štitaste žlezde:patogeneza Gravesove bolesti i Hashimoto tireoiditisa. Medicus 2003; 4: 21-6. 19. Sinclair D. Clinical and laboratory aspects of thyroid autoantibodies. Ann Clin Biochem 2006; 43: 173-83. 20. McLachlan SM, Nagayama Y, Pichurin PN, et al. The link between Graves’ disease and Hashimoto’s thyroiditis: A role for regulatory T

Open access

Anna Maria Dąbrowska and Agnieszka Zwolak

Neurosci. 2013;36:237-47. 4. Pasmant E, Vidaud M, Vidaud D, Wolkenstein P. Neurofibromatosis type 1: from genotype to phenotype. J Med Genet. 2012;49:483-9. 5. Crona J, Delgado Verdugo A, Maharjan R, et al. Somatic mutations in HRAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing. J Clin Endocrinol Metab. 2013;98:E1266-71. 6. Nabi J. Neurofibromatosis type 1 associated with Hashimoto’s thyroiditis: coincidence or possible link. Case Rep Neurol Med. 2013; 2013:910656. doi: 10.1155/2013/910656. PubMed PMID: 23691379; PubMed

Open access

Jovan Lalošević and Dušan Škiljević

1993;69:72-5. 7. Kataria YP, Holter JF. Immunology of sarcoidosis. Clin Chest Med 1997;18:719-39. 8. Passeron T, Ortonne JP. Physiopathology and genetics of vitiligo. J Autoimmun 2005;25 Suppl:63-8. 9. Weetman AP. The immunopathogenesis of chronic autoimmune thyro-iditis one century after hashimoto. Eur Thyroid J 2013;1:243-50. 10. Tchernev G, Ananiev J, Cardoso JC, Wollina U, Verma SB, Patterson JW, et al. Sarcoidosis and molecular mimicry-important etiopathogenetic aspects: current state and future directions. Wien Klin Wochenschr 2012

Open access

Lība Sokolovska, Alina Sultanova, Maksims Čistjakovs, Egils Cunskis and Modra Murovska

killer cells in Hashimoto’s thyroiditis associated with HHV-6 infection. Adv. Exp. Med. Biol. , 897 , 113–120. Secchiero, P., Carrigan, D. R., Asano, Y., Benedetti, L., Crowley, R. W., Komaroff, A. L., Gallo, R. C., Lusso, P. (1995). Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J. Infect. Dis ., 171 (2), 273–280. Sultanova, A., Cistjakovs, M., Cunskis, E., Todorova, K., Russev, R., Murovska, M. (2016). Thyrocytes as the target cells for Hhv-6 infection in

Open access

Violeta Mladenovic

replacement in Hashimoto’s thyroiditis. Thyroid 2010;20:901-908. 10. Cooper D. Subclinical thyroid disease. Lancet 2012;379:1142-54. 11. Horacek J, Spitalnikova S, Dlabalova B, Malirova E, Vizda J, Svilias I, et al. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol 2010;163:645-650. 12. Bebhaim RD, Davis TF. Increased risk of Graves’ disease after pregnancy. Thyroid 2005;15:1287-1290. 13. Stagnaro-Green A. Clinical review

Open access

Alina Sultanova, Maksims Èistjakovs, Egils Cunskis, Katerina Todorova, Russy Russev and Modra Murovska

of human herpesvirus-6, Epstein-Barr virus and cytomegalovirus in formalin- fixed tissues from sudden infant death: A study with quantitative real-time PCR. Forensic Sci. Int., 178 (2-3), 106-111. Caselli, E., Zatelli, M. C., Rizzo, R., Benedetti, S., Martorelli, D., Trasforini, G., Cassai, E., degli Uberti, E. C., Di Luca, D., Dolcetti, R. (2012). Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis. PLoS Pathog., 8 (10), e1002951. Chapenko, S, Millers, A, Nora, Z, Logina, I, Kukaine

Open access

Boyan Nonchev

;36:1051-66. Carella C, Mazziotti G, Amato G, et al. Interferon-α-related thyroid disease: Pathophysiological, epidemiological and clinical aspects. J Clin Endocrinol Metab 2004; 89(8):3656-61. Jamil KM, Leedman PJ, Kontorinis N, et al. Interferon-induced thyroid dysfunction in chronic hepatitis C. J Gastroenterol Hepatol 2009;24(6):1017-23. Mandac J, Chaudhry S, Sherman K, Tomer Y. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 2006

Open access

Cristina Corina Pop-Radu and Mirela Gliga

in thyroid diseases. Orv Hetil. 1997;138:2307. 23. Lotz H, Salabe GB. Lipoprotein(a) increase associated with thyroid autoimmunity. Eur J Endocrinol. 1997;136(1):87-91. 24. Bairaktari ET, Tselepis AD, Millionis HJ, Elisaf MS. Lipoprotein(a) levels, apoLipoprotein(a) phenotypes and thyroid autoimmunity. Eur J Endocrinol. 1999;140:474-6. 25. Tagami T, Tamanaha T, Shimazu S, et al. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with